Substance Abuse Detection

"Substance Abuse Detection" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Detection of drugs that have been abused, overused, or misused, including legal and illegal drugs. Urine screening is the usual method of detection.

Descriptor ID	D015813
MeSH Number(s)	E05.885 N06.850.780.500.765
Concept/Terms	Substance Abuse Detection Substance Abuse Detection Detection, Substance Abuse Detections, Substance Abuse Substance Abuse Detections Substance Abuse Testing Substance Abuse Testings Testing, Substance Abuse Testings, Substance Abuse Drug Abuse Screening Drug Abuse Screenings Screening, Drug Abuse Screenings, Drug Abuse Drug Abuse Testing Drug Abuse Testings Testing, Drug Abuse Testings, Drug Abuse Drug Abuse Detection Detection, Drug Abuse Detections, Drug Abuse Drug Abuse Detections Street Drug Testing Street Drug Testing Street Drug Testings Testing, Street Drug Testings, Street Drug Street Drug Detection Street Drug Detection Detection, Street Drug Detections, Street Drug Street Drug Detections Illicit Drug Detection Illicit Drug Detection Detection, Illicit Drug Detections, Illicit Drug Illicit Drug Detections Illicit Drug Testing Illicit Drug Testing Drug Testing, Illicit Drug Testings, Illicit Illicit Drug Testings Testing, Illicit Drug Testings, Illicit Drug

Below are MeSH descriptors whose meaning is more general than "Substance Abuse Detection".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Substance Abuse Detection [E05.885]
Health Care [N]
Environment and Public Health [N06]
Public Health [N06.850]
Public Health Practice [N06.850.780]
Mass Screening [N06.850.780.500]
Substance Abuse Detection [N06.850.780.500.765]

Below are MeSH descriptors whose meaning is related to "Substance Abuse Detection".

Below are MeSH descriptors whose meaning is more specific than "Substance Abuse Detection".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Substance Abuse Detection" by people in this website by year, and whether "Substance Abuse Detection" was a major or minor topic of these publications.

Bar chart showing 29 publications over 18 distinct years, with a maximum of 3 publications in 2007 and 2019 and 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2001	1	0	1
2003	2	0	2
2005	1	0	1
2006	1	0	1
2007	0	3	3
2008	0	1	1
2009	1	1	2
2011	1	0	1
2012	1	0	1
2013	2	0	2
2015	2	0	2
2016	1	0	1
2017	1	0	1
2018	1	1	2
2019	0	3	3
2020	1	0	1
2021	1	0	1
2024	1	2	3

Below are the most recent publications written about "Substance Abuse Detection" by people in Profiles.

Tolan NV, Kang P, Chai PR, Erickson TB, Hayes BD, Uljon SN, Demetriou CA, Melanson SEF. Impact of COVID-19 on Drug Positivity Rates in the Emergency Departments in Boston and Surrounding Areas. J Appl Lab Med. 2024 Nov 04; 9(6):1064-1070.

View in: PubMed
Babu KM, Haddad YK, Causey ST, Vargas-Torres CC, Martinez PM, Goldberg EM, Dorfman JD, Bleser JA, Chapman BP, Lai JT, Saif R, Elhoussan R, Graham LA, Krotulski AJ, Walton SE, Thomas FD, Logan BK, C Merchant R. Detection of ethanol, cannabinoids, benzodiazepines, and opioids in older adults evaluated for serious injuries from falls. Clin Toxicol (Phila). 2024 Oct; 62(10):661-668.

View in: PubMed
Uljon S, Tolan NV, Mahowald GK, Khaliq T, Urwiller ED, Fernandes MD, Basu SS, Kang P, Erickson TB, Hayes BD, Chai PR, Melanson SEF. Performance of a Norfentanyl Immunoassay in Specimens with Low Concentrations of Fentanyl and/or Norfentanyl. J Appl Lab Med. 2024 Sep 03; 9(5):895-904.

View in: PubMed
Erickson TB, Endo N, Duvallet C, Ghaeli N, Hess K, Alm EJ, Matus M, Chai PR. "Waste Not, Want Not" - Leveraging Sewer Systems and Wastewater-Based Epidemiology for Drug Use Trends and Pharmaceutical Monitoring. J Med Toxicol. 2021 10; 17(4):397-410.

View in: PubMed
Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, Caughey AB, Curry SJ, Donahue K, Doubeni CA, Epling JW, Kubik M, Ogedegbe G, Pbert L, Silverstein M, Simon MA, Tseng CW, Wong JB. Screening for Unhealthy Drug Use: US Preventive Services Task Force Recommendation Statement. JAMA. 2020 Jun 09; 323(22):2301-2309.

View in: PubMed
Ondersma SJ, Chang G, Blake-Lamb T, Gilstad-Hayden K, Orav J, Beatty JR, Goyert GL, Yonkers KA. Accuracy of five self-report screening instruments for substance use in pregnancy. Addiction. 2019 09; 114(9):1683-1693.

View in: PubMed
Babu KM, Brent J, Juurlink DN. Prevention of Opioid Overdose. N Engl J Med. 2019 06 06; 380(23):2246-2255.

View in: PubMed
Ecker J, Abuhamad A, Hill W, Bailit J, Bateman BT, Berghella V, Blake-Lamb T, Guille C, Landau R, Minkoff H, Prabhu M, Rosenthal E, Terplan M, Wright TE, Yonkers KA. Substance use disorders in pregnancy: clinical,?ethical, and research imperatives of?the?opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American Society of Addiction Medicine. Am J Obstet Gynecol. 2019 07; 221(1):B5-B28.

View in: PubMed
Alegr?a M, Falgas-Bague I, Collazos F, Carmona Camacho R, Lapatin Markle S, Wang Y, Baca-Garc?a E, L? Cook B, Chavez LM, Fortuna L, Herrera L, Qureshi A, Ramos Z, Gonz?lez C, Aroca P, Albarrac?n Garc?a L, Cellerino L, Villar A, Ali N, Mueser KT, Shrout PE. Evaluation of the Integrated Intervention for Dual Problems and Early Action Among Latino Immigrants With Co-occurring Mental Health and Substance Misuse Symptoms: A Randomized Clinical Trial. JAMA Netw Open. 2019 01 04; 2(1):e186927.

View in: PubMed
Martin SA, Chiodo LM, Bosse JD, Wilson A. The Next Stage of Buprenorphine Care for Opioid Use Disorder. Ann Intern Med. 2018 11 06; 169(9):628-635.

View in: PubMed

People

Explore

Similar Concepts

Top Journals